• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Otolin-1 与维生素 D 水平之间的关系。

A Relationship Between Blood Levels of Otolin-1 and Vitamin D.

机构信息

Division of Otolaryngology-Head & Neck Surgery, Department of Surgery.

Center on Aging.

出版信息

Otol Neurotol. 2018 Apr;39(4):e269-e273. doi: 10.1097/MAO.0000000000001747.

DOI:10.1097/MAO.0000000000001747
PMID:29533337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5854203/
Abstract

OBJECTIVE

Low vitamin D levels have been associated with and could play a role in the pathogenesis of idiopathic benign paroxysmal positional vertigo (iBPPV). Since otoconia degeneration contributes to iBPPV and a lack of vitamin D may impact otoconia structure and integrity, we proposed a negative association between vitamin D levels and levels of a proposed circulatory biomarker for otolithic degeneration, otolin-1.

STUDY DESIGN

Cross-sectional clinical study.

SETTING

Clinical research center.

PATIENTS

Seventy-nine men and women ranging in age from 22 to 95 years old without known vertigo.

INTERVENTIONS

Diagnostic.

MAIN OUTCOME MEASURES

Blood levels of 25-OH vitamin D and otolin-1.

RESULTS

Previously, we had reported higher otolin-1 levels in older age groups. The majority of the subjects (83%) had vitamin D levels that were below 40 ng/ml. Vitamin D level was lowest in the young and increased with age before declining in subjects 70 years of age and older (p = 0.005). There was a negative correlation between vitamin D and otolin-1 levels of subjects over 70 (r = -0.36, p = 0.036).

CONCLUSION

Our results demonstrate a relationship between vitamin D and otolin-1. The majority of our subjects had abnormally low vitamin D levels, but only those over 70 years of age showed a negative correlation with high otolin-1 levels. We postulate that a seasonal drop in vitamin D may not be sufficient for otoconia fragmentation and ultimately iBPPV, rather, chronically low vitamin D maybe required to induce otoconia degeneration.

摘要

目的

维生素 D 水平较低与特发性良性阵发性位置性眩晕(iBPPV)的发病机制有关,并且可能发挥作用。由于耳石变性导致 iBPPV,而维生素 D 缺乏可能影响耳石的结构和完整性,因此我们提出维生素 D 水平与耳石退化的一种拟议循环生物标志物 otolin-1 的水平之间存在负相关。

研究设计

横断面临床研究。

设置

临床研究中心。

患者

79 名年龄在 22 至 95 岁之间、无已知眩晕的男性和女性。

干预措施

诊断。

主要观察指标

血液中的 25-羟维生素 D 和 otolin-1 水平。

结果

此前,我们报告了年龄较大的组中 otolin-1 水平较高。大多数受试者(83%)的维生素 D 水平低于 40ng/ml。维生素 D 水平在年轻组中最低,随年龄增长而增加,然后在 70 岁及以上的受试者中下降(p=0.005)。70 岁以上的受试者的维生素 D 和 otolin-1 水平之间存在负相关(r=-0.36,p=0.036)。

结论

我们的结果表明维生素 D 与 otolin-1 之间存在关系。我们的大多数受试者的维生素 D 水平异常低,但只有 70 岁以上的受试者与高 otolin-1 水平呈负相关。我们推测维生素 D 的季节性下降可能不足以导致耳石碎片和最终 iBPPV,相反,慢性低维生素 D 可能需要诱导耳石变性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7552/5854203/85c5de0d5f5b/nihms935667f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7552/5854203/f235b50a788f/nihms935667f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7552/5854203/a457fedc1e56/nihms935667f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7552/5854203/85c5de0d5f5b/nihms935667f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7552/5854203/f235b50a788f/nihms935667f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7552/5854203/a457fedc1e56/nihms935667f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7552/5854203/85c5de0d5f5b/nihms935667f3.jpg

相似文献

1
A Relationship Between Blood Levels of Otolin-1 and Vitamin D.Otolin-1 与维生素 D 水平之间的关系。
Otol Neurotol. 2018 Apr;39(4):e269-e273. doi: 10.1097/MAO.0000000000001747.
2
An evaluation of serum Otolin-1 & Vitamin-D in benign paroxysmal positional vertigo.良性阵发性位置性眩晕患者血清 Otolin-1 和维生素 D 的评估。
J Vestib Res. 2021;31(6):433-440. doi: 10.3233/VES-201601.
3
Age-Related Increase in Blood Levels of Otolin-1 in Humans.人类血液中Otolin-1水平随年龄增长而升高。
Otol Neurotol. 2017 Jul;38(6):865-869. doi: 10.1097/MAO.0000000000001426.
4
Serum otolin-1 as a biomarker for benign paroxysmal positional vertigo: a case-control study.血清 otolin-1 作为良性阵发性位置性眩晕的生物标志物:一项病例对照研究。
J Laryngol Otol. 2021 Jul;135(7):589-592. doi: 10.1017/S0022215121001274. Epub 2021 Jun 17.
5
Preliminary Report on the Investigation of the Association Between BPPV and Osteoporosis Using Biomarkers.利用生物标志物对良性阵发性位置性眩晕与骨质疏松症之间关联的调查初步报告。
Otol Neurotol. 2015 Sep;36(9):1532-6. doi: 10.1097/MAO.0000000000000853.
6
Inner ear protein as a biomarker in circulation?内耳蛋白作为循环中的生物标志物?
Otolaryngol Head Neck Surg. 2014 Dec;151(6):1038-40. doi: 10.1177/0194599814551127. Epub 2014 Sep 22.
7
[Changes of serum E2 and Otolin-1 levels in postmenopausal women with BPPV].[良性阵发性位置性眩晕绝经后女性血清雌二醇和Otolin-1水平的变化]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Dec;33(12):1138-1141;1147. doi: 10.13201/j.issn.1001-1781.2019.12.006.
8
The Seasonal Variation of Benign Paroxysmal Positional Vertigo.良性阵发性位置性眩晕的季节变化
Otol Neurotol. 2017 Oct;38(9):1315-1318. doi: 10.1097/MAO.0000000000001534.
9
Low 25-hydroxyvitamin D levels in postmenopausal female patients with benign paroxysmal positional vertigo.绝经后女性良性阵发性位置性眩晕患者25-羟维生素D水平较低
Acta Otolaryngol. 2018 May;138(5):443-446. doi: 10.1080/00016489.2017.1416168. Epub 2017 Dec 22.
10
Increased Otolin-1 in Serum as a Potential Biomarker for Idiopathic Benign Paroxysmal Positional Vertigo Episodes.血清中Otolin-1升高作为特发性良性阵发性位置性眩晕发作的潜在生物标志物。
Front Neurol. 2020 May 13;11:367. doi: 10.3389/fneur.2020.00367. eCollection 2020.

引用本文的文献

1
Risk of Benign Paroxysmal Positional Vertigo Modified by Diuretics-A Population-Level Case-Control Study.利尿剂对良性阵发性位置性眩晕风险的影响——一项基于人群的病例对照研究
Otolaryngol Head Neck Surg. 2025 Sep;173(3):613-625. doi: 10.1002/ohn.1282. Epub 2025 May 5.
2
Association between otolin-1 and benign paroxysmal positional vertigo: A meta-analysis.耳石素-1与良性阵发性位置性眩晕的关联:一项荟萃分析。
Front Neurol. 2022 Dec 15;13:950023. doi: 10.3389/fneur.2022.950023. eCollection 2022.
3
Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors.基于内分泌及其他代谢因素的特发性良性阵发性位置性眩晕的病因与治疗
J Otol. 2020 Dec;15(4):155-160. doi: 10.1016/j.joto.2020.04.001. Epub 2020 Jun 1.
4
Unhealthy Lifestyle Is an Important Risk Factor of Idiopathic BPPV.不健康的生活方式是特发性良性阵发性位置性眩晕的重要危险因素。
Front Neurol. 2020 Oct 15;11:950. doi: 10.3389/fneur.2020.00950. eCollection 2020.
5
Prevention of recurrent benign paroxysmal positional vertigo with vitamin D supplementation: a meta-analysis.补充维生素D预防复发性良性阵发性位置性眩晕:一项荟萃分析。
J Neurol. 2022 Feb;269(2):619-626. doi: 10.1007/s00415-020-09952-8. Epub 2020 Aug 7.
6
Association between benign paroxysmal positional vertigo and osteoporosis: two nested case-control studies.良性阵发性位置性眩晕与骨质疏松症的关联:两项巢式病例对照研究。
Osteoporos Int. 2020 Oct;31(10):2017-2024. doi: 10.1007/s00198-020-05478-x. Epub 2020 Jun 1.
7
Association between bone mineral density and benign paroxysmal positional vertigo: a meta-analysis.骨密度与良性阵发性位置性眩晕的相关性:荟萃分析。
Eur Arch Otorhinolaryngol. 2019 Jun;276(6):1561-1571. doi: 10.1007/s00405-019-05345-4. Epub 2019 Apr 27.
8
Vitamin D supplementation may improve symptoms in Meniere's disease.维生素 D 补充剂可能改善梅尼埃病的症状。
Med Hypotheses. 2018 Jul;116:44-46. doi: 10.1016/j.mehy.2018.04.019. Epub 2018 Apr 24.

本文引用的文献

1
25 (OH) D3 levels, incidence and recurrence of different clinical forms of benig paroxysmal positional vertigo.25(羟)维生素D3水平、不同临床类型良性阵发性位置性眩晕的发病率及复发情况。
Braz J Otorhinolaryngol. 2018 Jul-Aug;84(4):453-459. doi: 10.1016/j.bjorl.2017.05.007. Epub 2017 Jun 11.
2
Age-Related Increase in Blood Levels of Otolin-1 in Humans.人类血液中Otolin-1水平随年龄增长而升高。
Otol Neurotol. 2017 Jul;38(6):865-869. doi: 10.1097/MAO.0000000000001426.
3
Biochemical markers of bone turnover in benign paroxysmal positional vertigo.良性阵发性位置性眩晕中骨转换的生化标志物
PLoS One. 2017 May 3;12(5):e0176011. doi: 10.1371/journal.pone.0176011. eCollection 2017.
4
Association of Benign Paroxysmal Positional Vertigo with Osteoporosis and Vitamin D Deficiency: A Case Controlled Study.良性阵发性位置性眩晕与骨质疏松症和维生素D缺乏的关联:一项病例对照研究。
J Int Adv Otol. 2017 Aug;13(2):259-265. doi: 10.5152/iao.2016.2640. Epub 2017 Mar 9.
5
The effect of serum vitamin D normalization in preventing recurrences of benign paroxysmal positional vertigo: A case-control study.血清维生素D正常化对预防良性阵发性位置性眩晕复发的作用:一项病例对照研究。
Caspian J Intern Med. 2016 Summer;7(3):173-177.
6
Calcium Homeostasis During Attack and Remission in Patients With Idiopathic Benign Paroxysmal Positional Vertigo.特发性良性阵发性位置性眩晕患者发作期与缓解期的钙稳态
Otol Neurotol. 2016 Oct;37(9):1388-92. doi: 10.1097/MAO.0000000000001167.
7
Influence of supplemental vitamin D on intensity of benign paroxysmal positional vertigo: A longitudinal clinical study.补充维生素D对良性阵发性位置性眩晕强度的影响:一项纵向临床研究。
Caspian J Intern Med. 2016 Spring;7(2):93-8.
8
A Geriatric Perspective on Benign Paroxysmal Positional Vertigo.老年视角下的良性阵发性位置性眩晕
J Am Geriatr Soc. 2016 Feb;64(2):378-85. doi: 10.1111/jgs.13926. Epub 2016 Jan 25.
9
Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency.通过治疗严重维生素D缺乏症降低良性阵发性位置性眩晕的复发率
Auris Nasus Larynx. 2016 Jun;43(3):237-41. doi: 10.1016/j.anl.2015.08.009. Epub 2015 Sep 16.
10
Preliminary Report on the Investigation of the Association Between BPPV and Osteoporosis Using Biomarkers.利用生物标志物对良性阵发性位置性眩晕与骨质疏松症之间关联的调查初步报告。
Otol Neurotol. 2015 Sep;36(9):1532-6. doi: 10.1097/MAO.0000000000000853.